Page last updated: 2024-12-11

4-(3',4'-dimethoxyphenyl)but-3-en-1-ol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-(3',4'-dimethoxyphenyl)but-3-en-1-ol: uterine relaxant isolated from Zingiber cassumunar Roxb. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Zingibergenus[no description available]ZingiberaceaeA plant family of the order Zingiberales, subclass Zingiberidae, class Liliopsida. It includes plants which have both flavoring and medicinal properties such as GINGER; turmeric (CURCUMA), and cardamom (ELETTARIA).[MeSH]
Zingiber cassumunarspecies[no description available]ZingiberaceaeA plant family of the order Zingiberales, subclass Zingiberidae, class Liliopsida. It includes plants which have both flavoring and medicinal properties such as GINGER; turmeric (CURCUMA), and cardamom (ELETTARIA).[MeSH]

Cross-References

ID SourceID
PubMed CID6439118
SCHEMBL ID4092723
SCHEMBL ID2684387
MeSH IDM0152212

Synonyms (13)

Synonym
4-(3,4-dimethoxyphenyl)-3-buten-1-ol
dmp-butenol
(e)-4-(3,4-dimethoxyphenyl)but-3-en-1-ol
4-(3',4'-dimethoxyphenyl)but-3-en-1-ol
69768-97-4
3-buten-1-ol, 4-(3,4-dimethoxyphenyl)-, (e)-
AKOS022184721
SCHEMBL4092723
SCHEMBL2684387
3-buten-1-ol, 4-(3,4-dimethoxyphenyl)-, (3e)-
(e)-4-(3,4-dimethoxyphenyl)-but-3-en-1-ol
methyl2-cyano-5-methoxybenzoate
FS-8969

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" In this study, we examined the pharmacokinetic profiles of Compound D in male Wistar rats."( Pharmacokinetics of Compound D, the Major Bioactive Component of Zingiber cassumunar, in Rats.
Anukunwithaya, T; Bangphumi, K; Dechatiwongse Na Ayudhya, T; Hunsakunachai, N; Inthachart, T; Jiratchariyakul, W; Khemawoot, P; Koontongkaew, S; Ongpipattanakul, B; Poachanukoon, O; Soawakontha, R, 2016
)
0.43

Dosage Studied

ExcerptRelevanceReference
" Blood, tissues, urine, and feces were collected from 0 to 48 h after dosing and the level of Compound D was determined by liquid chromatography-tandem mass spectrometry."( Pharmacokinetics of Compound D, the Major Bioactive Component of Zingiber cassumunar, in Rats.
Anukunwithaya, T; Bangphumi, K; Dechatiwongse Na Ayudhya, T; Hunsakunachai, N; Inthachart, T; Jiratchariyakul, W; Khemawoot, P; Koontongkaew, S; Ongpipattanakul, B; Poachanukoon, O; Soawakontha, R, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.53 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]